Found: 9
Select item for more details and to access through your institution.
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1554, doi. 10.1002/ajh.26329
- By:
- Publication type:
- Article
Plasma Cell Myeloma Presenting With Amyloid-Laden Crystal-Negative Histiocytosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Age matters: Young T lymphocytes offer better protection from myeloma proliferation.
- Published in:
- Immunity & Ageing, 2013, v. 10, p. 1, doi. 10.1186/1742-4933-10-5
- By:
- Publication type:
- Article
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. 539, doi. 10.1002/ajh.25435
- By:
- Publication type:
- Article
Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 4, p. 433, doi. 10.1002/ajh.23108
- By:
- Publication type:
- Article
Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 5, p. 654, doi. 10.1111/j.1365-2141.2008.07374.x
- By:
- Publication type:
- Article
Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 5, p. 640, doi. 10.1111/j.1365-2141.2007.06698.x
- By:
- Publication type:
- Article
Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 2, p. 278, doi. 10.1046/j.1365-2141.2002.03257.x
- By:
- Publication type:
- Article
Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.1020011
- By:
- Publication type:
- Article